BRIAN SHANNON: Open Payments
NPI 1003214842 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 94 payments from 16 companies in 2025. Trend: 2023 $219 · 2024 $1,297 · 2025 $1,575
Food & beverage: $1,496Education: $79
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 29 | $419 |
| Regeneron Healthcare Solutions, Inc. | 11 | $179 |
| GENZYME CORPORATION | 11 | $155 |
| Verona Pharma, Inc. | 10 | $148 |
| AstraZeneca Pharmaceuticals LP | 8 | $148 |
| Insmed, Inc. | 5 | $93 |
| Philips North America LLC | 4 | $84 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Actelion Pharmaceuticals US, Inc. | 3 | $46 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, TRELEGY ELLIPTA, Arikayce, Vest Therapy Und, FASENRA, ARALAST.
Industry payments across NJ — which companies pay providers there.
